EMA Authorised: Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan) (lopinavir;ritonavir) — Viatris Limited

View source ↗

Summary

The European Medicines Agency authorised Lopinavir/Ritonavir Viatris for HIV infections, with Viatris Limited listed as the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir/ritonavir Viatris (lopinavir/ritonavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 05/09/2025